Suchergebnisse - "SCHOLLER JOHN"

PubPharm (31)

1

Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation

enthalten in: Nature communications | 2024

von Berjis, A. | Muthumani, D. | Aguilar, O. | +10

2

Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies

enthalten in: Cell reports. Medicine | 2023

von Zhang, Z. | Markmann, C. | Yu, M. | +23

3

Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors

enthalten in: Nature communications | 2023

von Xiao, Z. | Todd, L. | Huang, L. | +14

UpdateOf: bioRxiv. 2023 Aug 07;:. - PMID 37090547

4

Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma

enthalten in: Blood advances | 2023

von Watanabe, K. | Gomez, A. | Kuramitsu, S. | +12

5

Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Mai, D. | Johnson, O. | Reff, J. | +4

6

Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy

enthalten in: Molecular therapy : the journal of the American Society of Gene Therapy | 2023

von Uribe-Herranz, M. | Beghi, S. | Ruella, M. | +25

7

Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Lee, I. | Noguera-Ortega, E. | Xiao, Z. | +12

CommentIn: Clin Cancer Res. 2022 Dec 15;28(24):5241-5243. - PMID 36250927

8

Potentiating adoptive cell therapy using synthetic IL-9 receptors

enthalten in: Nature | 2022

von Kalbasi, A. | Siurala, M. | Su, L. | +20

CommentIn: Cell Res. 2022 Nov;32(11):967-968. - PMID 36002586

9

PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer : a phase 1 trial

enthalten in: Nature medicine | 2022

von Narayan, V. | Barber-Rotenberg, J. | Jung, I. | +66

CommentIn: Nat Med. 2022 Apr;28(4):635-636. - PMID 35314844

10

Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function

enthalten in: Journal for immunotherapy of cancer | 2021

von Wang, H. | Chen, H. | Liu, S. | +21